Oruka Therapeutics Inc Share Price Today
(NASDAQ: ORKA)

Name: Oruka Therapeutics Inc Share Price (NASDAQ: ORKA) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Oruka Therapeutics Inc share price is $9.64 & ₹824.05 as on 10 May 2025, 2.30 'hrs' IST

$9.64

▲

-0.11

(-1.13%)

Market is closed - opens 7 PM, 12 May 2025

View live Oruka Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Oruka Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oruka Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Oruka Therapeutics Inc share price movements

Today's Low: $9.49
Today's High: $9.68
$9.64
1.56%
Downside
Day's Volatility :1.91%
Upside
0.36%
52 Weeks Low: $5.49
52 Weeks High: $31.13
$9.64
43.1%
Downside
52 Weeks Volatility :82.38%
Upside
69.03%

Oruka Therapeutics Inc (ORKA) Returns

Period	Oruka Therapeutics Inc	Index (Russel 2000)
3 Months	-12.56%	0.0%
6 Months	-64.16%	0.0%
1 Year	-76.62%	0.0%
3 Years	-65.58%	1.7%

Oruka Therapeutics Inc (ORKA) Key Statistics

in dollars & INR

Previous Close	$9.75
Open	$9.49
Today's High	$9.675
Today's Low	$9.49
Market Capitalization	$888.3M
Today's Volume	$104.0K
52 Week High	$31.13
52 Week Low	$5.485
Revenue TTM	$0.0
Dividend Yield	0.0%
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Oruka Therapeutics Inc Stock (ORKA) from India?

It is very easy for Indian residents to invest directly in Oruka Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oruka Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oruka Therapeutics Inc or ORKA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oruka Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oruka Therapeutics Inc shares which would translate to 0.089 fractional shares of Oruka Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oruka Therapeutics Inc, in just a few clicks!

Returns in Oruka Therapeutics Inc (ORKA) for Indian investors in Rupees

The Oruka Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Oruka Therapeutics Inc investment value today

Current value as on today

₹26,009

Returns

₹73,991

(-73.99%)

Returns from Oruka Therapeutics Inc Stock

₹76,373 (-76.37%)

Dollar Returns

₹2,382 (+2.38%)

Indian investors sentiment towards Oruka Therapeutics Inc (ORKA)

25%

Period: Apr 11, 2025 to May 11, 2025. Change in 30 Days versus previous period

Search interest for Oruka Therapeutics Inc Stock from India on INDmoney has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Oruka Therapeutics Inc

Rating

Trend

Insights on ORKA Stock (Ticker Symbol: ORKA)

Price Movement
In the last 6 months, ORKA stock has moved down by -63.4%
ORKA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.9% return, outperforming this stock by 144.0%
ORKA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 107.0% return, outperforming this stock by 172.4%

Oruka Therapeutics Inc (ORKA) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Regeneron Pharmaceuticals, Inc.	-7.58%	-36.08%	-45.98%	-18.24%	-8.55%
Vertex Pharmaceuticals Incorporated	-14.29%	-15.29%	-1.15%	72.26%	53.41%
Alnylam Pharmaceuticals, Inc.	4.64%	-10.25%	67.56%	98.58%	80.09%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Regeneron Pharmaceuticals, Inc.	13.42	NA	NA	NA	NA	NA	NA	NA
Vertex Pharmaceuticals Incorporated	32.84	NA	NA	NA	NA	NA	NA	NA
Alnylam Pharmaceuticals, Inc.	NA	NA	NA	NA	NA	NA	NA	NA

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Regeneron Pharmaceuticals, Inc.	Buy	$57.0B	-8.55%	13.42	NA
Vertex Pharmaceuticals Incorporated	Buy	$109.1B	53.41%	32.84	NA
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	80.09%	NA	NA

About Oruka Therapeutics Inc

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Organization	Oruka Therapeutics Inc
Employees	28
CEO	Dr. Lawrence Otto Klein Ph.D.
Industry	Miscellaneous

Management People of Oruka Therapeutics Inc

Name	Title
Dr. Lawrence Otto Klein Ph.D.	President, CEO & Director
Mr. Paul T. Quinlan	General Counsel & Secretary
Dr. Joana Goncalves M.D.	Chief Medical Officer
Mr. Arjun Agarwal CPA	Senior VP of Finance & Treasurer
Ms. Laura Sandler	Senior Vice President of Operations & Boston Site Head
Mr. Alan Lada	Vice President of Investor Relations
Mr. Christopher Finch	Vice President of Corporate Development & Strategy
Dr. Rajiv Panwar	VP and Head of Chemistry, Manufacturing & Controls
Dr. Joe Senn Ph.D.	Senior Vice President of Nonclinical Research & Development

Important FAQs about investing in ORKA Stock from India :

Can Indians buy Oruka Therapeutics Inc shares?

Yes, Indians can invest in the Oruka Therapeutics Inc (ORKA) from India.

With INDmoney, you can buy Oruka Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Oruka Therapeutics Inc at zero transaction cost.

How can I buy Oruka Therapeutics Inc shares from India?

It is very easy to buy Oruka Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oruka Therapeutics Inc (ORKA) be purchased?

Yes, you can buy fractional shares of Oruka Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Oruka Therapeutics Inc stocks?

To start investing in Oruka Therapeutics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Oruka Therapeutics Inc share price today?

Oruka Therapeutics Inc share price today stands at $9.64, Open: $9.49 ; Previous Close: $9.75 ; High: $9.68 ; Low: $9.49 ; 52 Week High: $31.13 ; 52 Week Low: $5.49.

The stock opens at $9.49, after a previous close of $9.75. The stock reached a daily high of $9.68 and a low of $9.49, with a 52-week high of $31.13 and a 52-week low of $5.49.